SCHEMBL25043524

SCHEMBL25043524

C/C(=C\C(=O)O)C(=O)OC1(c2ccc(C(F)(F)F)cc2)CCC1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NR4A1 P22736 1/20 0.46
▸ NR4A2 P43354 1/20 0.46
▸ NR4A3 Q92570 1/20 0.46
▸ OPRM1 P35372 1/20 0.36
▸ OPRL1 P41146 1/20 0.36
▸ APP P05067 1/20 0.35
▸ THRB P10828 1/20 0.34
▸ PDE2A O00408 4/20 0.34
▸ SLC6A3 Q01959 5/20 0.34
▸ SLC6A4 P31645 4/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ PDPK1 O15530 1/20 0.34
▸ LTB4R Q15722 1/20 0.33
▸ LTB4R2 Q9NPC1 1/20 0.33
▸ BACE1 P56817 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24394138 0.82 NR4A1 (0.40) NR4A1NR4A2NR4A3OPRM1OPRL1
SCHEMBL29588039 0.82 NR4A1 (0.40) NR4A1NR4A2NR4A3OPRM1OPRL1
SCHEMBL25564666 0.79 SLC6A3 (0.40) NR4A1NR4A2NR4A3OPRM1OPRL1
SCHEMBL25564144 0.78 SLC6A3 (0.43) NR4A1NR4A2NR4A3OPRM1OPRL1
SCHEMBL24616758 0.78 APP (0.37) NR4A1NR4A2NR4A3OPRM1OPRL1
SCHEMBL25564245 0.77 SLC6A3 (0.46) NR4A1NR4A2NR4A3OPRM1OPRL1
SCHEMBL24397836 0.75 SLC6A3 (0.36) NR4A1NR4A2NR4A3OPRM1OPRL1
SCHEMBL25042483 0.75 THRB (0.37) OPRM1OPRL1APPTHRBPDE2A
SCHEMBL24394134 0.75 GSK3B (0.44) OPRM1OPRL1APPTHRBPDE2A
SCHEMBL24616782 0.74 ALDH1A1 (0.42) OPRM1OPRL1APPTHRBPDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023017269-A1 DERIVATIVES OF ITACONIC ACID AND THEIR USE AS ANTI-INFLAMMATORY AGENTS SITRYX THERAPEUTICS LIMITED (GB) 2023-02-16 — — WO disclosed
Send feedback